Monash IVF Group Limited
ASX: MVF
Revenue Growth Holds Steady as Market Share Expands in Key Segments
(Source: TradingView) 3-Month Performance Profile of MVF on a DTF compared to ASX 200 (XJO)
Monash IVF reported FY25 revenue of $271.9 million, a 6.7% increase from the previous year, supported by strength across IVF, ultrasound, genetics, and day-surgery services. Underlying EBITDA rose 5.6% to
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
